Search

everythinglearnresearchcommunity

for

Search:↓

Removing MCPIP1 from myeloid cells in mice leads to hair loss and prevents skin tumors but causes pigmented spots.

Understanding where cancer cells come from helps create better prevention and treatment methods.

Krt15+ cells in the mouse intestine resist radiation and can start tumors.

The drug combination was safe and showed promise in treating advanced tumors.

Skin cells show flexibility in healing wounds and forming tumors, with potential for treating hair disorders and chronic ulcers.

A woman with unexplained hair loss was found to have harmless skin tumors and a scarring hair loss condition, but the tumors didn't cause the hair loss.

A young woman had a rare tumor causing high male hormone levels and symptoms like excessive hair and acne. After removing the tumor, her hormone levels returned to normal. Early diagnosis is important.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Trichoblastomas in rabbits are linked to uncontrolled embryonic hair growth and have distinct histological features.

Putting thymidine dinucleotide on newborn mice's skin can delay and reduce skin cancer.

The document says that common skin conditions in adult women can be treated effectively, with acne being the most common and early-detected melanoma having a high survival rate.

External factors can cause skin cancer cells that usually don't spread to grow and form tumors in mice.

The reviewers found the manuscript on inflammation's role in cancer stem cells to be relevant but suggested it needs clarity, more background information, discussion on immune cells' role in tumors, updated references, and grammar corrections.

The reviewers suggest clarifying the abstract, adding background on inflammation's effect on stem cells and cancer, discussing immune cells' role in tumors, and considering inflammation's potential to reduce cancer growth.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

A rare ovarian tumor caused high testosterone and excess hair in a woman, which was resolved after tumor removal.

An 86-year-old man with prostate cancer was diagnosed with a rare, low-grade breast cancer and underwent surgery but declined additional hormone therapy.

Basal cell carcinomas have much higher levels of Vitamin D3 receptors compared to healthy skin.

Photodynamic therapy was effective in treating multiple scalp basal cell carcinomas with minimal side effects and good cosmetic results.

Breast cancer skin metastases are rare, look different, and can be confused with other skin issues, so a biopsy is needed for accurate diagnosis.

Deleting the Trf1 protein in mice is safe and may help prevent cancer without major side effects.

Scalp basal cell carcinoma may be more aggressive and harder to treat than other types, requiring special attention and further research.

A 63-year-old woman's male-like symptoms were caused by a rare testosterone-producing ovarian tumor, treated by removing her ovaries and fallopian tubes.

The health of the sentinel lymph node is the best indicator of survival for patients with thick skin cancer.

Hair loss in postmenopausal women due to ovarian hyperthecosis is rare, but removing the ovaries can significantly improve the condition.

Giant solitary trichoepithelioma is a rare, usually non-cancerous hair follicle tumor that can sometimes turn into skin cancer.

High TSPEAR levels in colorectal cancer predict worse outcomes.

Skin lesions in Carney complex are likely caused by a specific group of skin cells that promote pigment production due to a genetic mutation.

High TSPEAR levels in colorectal cancer predict worse outcomes.

A man had a non-cancerous neck tumor related to hair follicles removed with no return of the tumor.